Vaccine Information: Pfizer-BioNTech Covid-19 Vaccine (Page 6 of 6)
PRINCIPAL DISPLAY PANEL — 1.8 mL Vial Label
Pfizer-BioNTech COVID-19 Vaccine
After dilution, vial contains 6 doses of 0.3 mL
For intramuscular use. Contains no preservative.
For use under Emergency Use Authorization.
DILUTE BEFORE USE. Discard 6 hours afterdilution when stored at 2 to 25°C (35 to 77°F).
Dilution date and time:
NDC 59267-1000-1
PRINCIPAL DISPLAY PANEL — 195 Vial Carton Label
NDC 59267-1000-2
Pfizer-BioNTech COVID-19 Vaccine
Suspension for Intramuscular Injection
195 Multiple Dose Vials
(after dilution each vial contains
6 doses of 0.3 mL)
Pfizer BIONTECH
STORAGE: Prior to dilution, store at
-80°C to -60°C (-112°F to -76°F).
Store in this carton to protect from light.
DOSAGE AND ADMINISTRATION: After
dilution, each vial contains 6 doses of 0.3 mL.
See FDA-authorized Fact Sheet or scan
QR code for information.
MUST BE DILUTED BEFORE USE with sterile
0.9% Sodium Chloride Injection, USP (not supplied).
After dilution, store the vaccine at 2°C to 25°C (35°F to 77°F).
Discard after 6 hours.
Contains no preservative.
For use under Emergency Use Authorization.
Rx only
Manufactured by
Pfizer Inc
New York, NY 10017
Manufactured for
BioNTech
Manufacturing GmbH
An der Goldgrube 1255131 Mainz, Germany
PAA166261
LOT:
EXP:
PRINCIPAL DISPLAY PANEL — 25 Vial Carton
NDC 59267-1000-3
Rx only
Pfizer-BioNTech COVID-19 Vaccine
Suspension for Intramuscular Injection
25 Multiple Dose Vials
(after dilution each vial contains 6 doses of 0.3 mL)
MUST BE DILUTED BEFORE USE with sterile
0.9% Sodium Chloride Injection, USP (not supplied).
After dilution, store the vaccine at 2°C to 25°C (35°F to 77°F).Discard after 6 hours.
PFIZER-BIONTECH COVID-19 VACCINE bnt162b2 injection, suspension | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
|
Labeler — Pfizer Manufacturing Belgium NV (370156507) |
Registrant — Pfizer Inc (113480771) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Pfizer Manufacturing Belgium NV | 370156507 | ANALYSIS (59267-1000), MANUFACTURE (59267-1000), PACK (59267-1000), LABEL (59267-1000) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Pharmacia & Upjohn Company LLC | 618054084 | ANALYSIS (59267-1000), MANUFACTURE (59267-1000), PACK (59267-1000), LABEL (59267-1000) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 174350868 | ANALYSIS (59267-1000), API MANUFACTURE (59267-1000) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Pfizer Inc | 004954111 | ANALYSIS (59267-1000) |
Revised: 04/2021 Pfizer Manufacturing Belgium NV
VxLabels.com provides trustworthy package insert and label information about marketed drugs and vaccines as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VxLabels.com. Every individual vaccine label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.
https://vxlabels.com/lib/vaccines/vax/pfizer-biontech-covid-19-vaccine/page/6/